1,074 research outputs found

    Adjuvant chemotherapy and survival among patients 70 years of age and younger with node-negative breast cancer and the 21-gene recurrence score of 26-30

    Get PDF
    BACKGROUND: The benefits of chemotherapy in node-negative, hormone receptor-positive, and human epidermal growth factor receptor 2 (HER2)-negative breast cancer patients with the 21-gene recurrence score (RS) of 18-30, particularly those with RS 26-30, are not known. METHODS: Using the Surveillance, Epidemiology, and End Results (SEER) data, we retrospectively identified 29,137 breast cancer patients with the 21-gene RS of 18-30 diagnosed between 2004 and 2015. Mortality risks according to the RS and chemotherapy use were compared by the Kaplan-Meier method and Cox\u27s proportional hazards model. RESULTS: Among the breast cancer patients with the RS 18-30, 21% of them had RS 26-30. Compared to breast cancer patients with RS 18-25, patients with RS 26-30 had more aggressive tumor characteristics and chemotherapy use and increased risk of breast cancer-specific mortality and overall mortality. In breast cancer patients who were aged ≀ 70 years and had RS of 26-30, chemotherapy administration was associated with a 32% lower risk of breast cancer-specific mortality (hazard ratio [HR], 0.68; 95% confidence interval [CI], 0.47-0.99) and a 42% lower risk of overall mortality (HR, 0.58; 95% CI, 0.44-0.76). Survival benefits were most pronounced in breast cancer patients who were younger or had grade III tumor. CONCLUSIONS: The 21-gene RS of 18-30 showed heterogeneous outcomes, and the RS 26-30 was a significant prognostic factor for an increased risk of mortality. Adjuvant chemotherapy could improve the survival of node-negative, hormone receptor-positive, and HER2-negative breast cancer patients with the 21-gene RS 26-30 and should be considered for patients, especially younger patients or patients with high-grade tumors

    Anxiety and depression after spontaneous subarachnoid hemorrhage

    Get PDF

    Structured interviews for the Glasgow Outcome Scale and the extended Glasgow Outcome Scale: Guidelines for their use

    Get PDF
    The Glasgow Outcome Scale (GOS) is the most widely used outcome measure after traumatic brain injury, but it is increasingly recognized to have important limitations. It is proposed that shortcomings of the GOS can be addressed by adopting a standard format for the interview used to assign outcome. A set of guidelines are outlined that are directed at the main problems encountered in applying the GOS. The guidelines cover the general principles underlying the use of the GOS and common practical problems of applying the scale. Structured interview schedules are described for both the five-point GOS and an extended eight-point GOS (GOSE). An interrater reliability study of the structured interviews for the GOS and GOSE yielded weighted kappa values of 0.89 and 0.85, respectively. It is concluded that assessment of the GOS using a standard format with a written protocol is practical and reliable

    A Manual for the Glasgow Outcome Scale-Extended Interview

    Get PDF
    The Glasgow Outcome Scale-Extended (GOSE) has become one of the most widely used outcome instruments to assess global disability and recovery after traumatic brain injury. Achieving consistency in the application of the assessment remains a challenge, particularly in multi-center studies involving many assessors. We present a manual for the GOSE interview that is designed to support both single- and multi-center studies and promote inter-rater agreement. Many patients fall clearly into a particular category; however, patients may have outcomes that are on the borderline between adjacent categories, and cases can present other challenges for assessment. The Manual includes the general principles of assessment, advice on administering each section of the GOSE interview, and guidance on “borderline” and “difficult” cases. Finally, we discuss the properties of the GOSE, including strengths and limitations, and outline recommendations for assessor training, accreditation, and monitoring

    Next-Generation Comprehensive Data-Driven Models of Solar Eruptive Events

    Full text link
    Solar flares and coronal mass ejections are interrelated phenomena that together are known as solar eruptive events. These are the main drivers of space weather and understanding their origins is a primary goal of Heliophysics. In this white paper, we advocate for the allocation of sufficient resources to bring together experts in observations and modeling to construct and test next generation data-driven models of solar eruptive events. We identify the key components necessary for constructing comprehensive end-to-end models including global scale 3D MHD resolving magnetic field evolution and reconnection, small scale simulations of particle acceleration in reconnection exhausts, kinetic scale transport of flare-accelerated particles into the lower solar atmosphere, and the radiative and hydrodynamics responses of the solar atmosphere to flare heating. Using this modeling framework, long-standing questions regarding how solar eruptive events release energy, accelerate particles, and heat plasma can be explored. To address open questions in solar flare physics, we recommend that NASA and NSF provide sufficient research and analysis funds to bring together a large body of researchers and numerical tools to tackle the end-to-end modeling framework that we outline. Current dedicated theory and modeling funding programs are relatively small scale and infrequent; funding agencies must recognize that modern space physics demands the use of both observations and modeling to make rapid progress.Comment: White paper submitted to the Decadal Survey for Solar and Space Physics (Heliophysics) 2024-2033; 9 pages, 4 figure

    Switching the stereochemical outcome of 6-endo-trig cyclizations; Synthesis of 2,6-Cis-6-substituted 4-oxopipecolic acids

    Get PDF
    A base-mediated 6-endo-trig cyclization of readily accessible enone-derived α-amino acids has been developed for the direct synthesis of novel 2,6-cis-6- substituted-4-oxo-L-pipecolic acids. A range of aliphatic and aryl side chains were tolerated by this mild procedure to give the target compounds in good overall yields. Molecular modeling of the 6-endo-trig cyclization allowed some insight as to how these compounds were formed, with the enolate intermediate generated via an equilibrium process, followed by irreversible tautomerization/neutralization providing the driving force for product formation. Stereoselective reduction and deprotection of the resulting 2,6-cis-6-substituted 4-oxo-L-pipecolic acids to the corresponding 4-hydroxy-L-pipecolic acids was also performed

    The Unusually Long Duration Gamma-ray Burst GRB 000911: Discovery of the afterglow and host galaxy

    Get PDF
    Of all the well-localized gamma-ray bursts, GRB 000911 has the longest duration (T90 = 500 s) and ranks in the top 1% of BATSE bursts for fluence. Here we report the discovery of the afterglow of this unique burst. In order to simultaneously fit our radio and optical observations, we are required to invoke a model involving a hard electron distribution, p ∌ 1.5, and a jet-break time less than 1.5 days. A spectrum of the host galaxy taken 111 days after the burst reveals a single emission line, interpreted as [011] at a redshift z = 1.0585, and a continuum break that we interpret as the Balmer limit at this redshift. Despite the long 790, the afterglow of GRB 000911 is not unusual in any other way when compared to the set of afterglows studied to date. We conclude that the duration of the GRB plays little part in determining the physics of the afterglow.P. A. P. gratefully acknowledges an Alex Rodgers Travelling Scholarship. J. S. B. gratefully acknowledges the fellowship support from the Fannie and John Hertz Foundation. K. H. is grateful for Ulysses support under JPL contract 958056, and for IPN support under the NEAR Participating Scientist program, NAG 5-9503, and under the LTSA, NAG 5-3500. The Konus/Wind experiment was supported by RFBR grant 99-02-017031 and CRDF grant RPI-2260
    • 

    corecore